LEP and metabolic dysfunction-associated steatotic liver disease: There were significant differences in glycemic profile (glucose, insulin, and HOMA-IR) and other metabolic parameters, such as leptin, ALT, AST, and ARFI values, in the NAFLD group compared to the control group.